Sprint Bioscience AB
9Patents
9Active
9Granted
48Portfolio score
Filing activity: Feb 17, 2017 → Nov 18, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11179399B2 | 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes | Chemistry; Metallurgy | 2 | Active |
| US11633403B2 | 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes | Chemistry; Metallurgy | 2 | Active |
| US11208423B2 | Pyridinamine-pyridone and pyrimidinamine- pyridone compounds | Human Necessities | 2 | Active |
| US11219618B2 | Pyridylpyridone compounds | Chemistry; Metallurgy | 2 | Active |
| US11560374B2 | Morpholinylpyridone compounds | Chemistry; Metallurgy | 0 | Active |
| US11780858B2 | Pyridinamine-pyridone and pyrimidinamine-pyridone compounds | Human Necessities | 0 | Active |
| US11077113B2 | 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes | Chemistry; Metallurgy | 0 | Active |
| US11498919B2 | Azaindolylpyridone and diazaindolylpyridone compounds | Human Necessities | 0 | Active |
| US11963963B2 | 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.